HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effects of monotherapy or combined therapy with an angiotensin converting enzyme inhibitor following initial treatment with calcium channel blockers on residual cardiovascular abnormalities.

Abstract
The effects of sequential therapy with angiotensin-converting enzyme inhibitor (cilazapril) on left ventricular (LV) mass, LV diastolic function, and carotid artery distensibility were evaluated in 90 hypertensive patients whose blood pressure controlled below 140/90 mmHg with a calcium channel blocker monotherapy. The possibility of predicting the efficacy of cilazapril based on evaluation of biochemical and genetic markers of the renin-angiotensin system was examined. Before cilazapril therapy, LV diastolic function and carotid artery distensibility were significantly impaired in 32 patients with residual LV hypertrophy compared with patients without LV hypertrophy. Cilazapril improved the LV mass in these patients with LV hypertrophy and improved LV diastolic function in a subset of 20 patients with elevated plasma renin activity. Patients with residual LV hypertrophy accompanied by cardiovascular functional abnormalities. Subsequent treatment with cilazapril significantly improved LV morphology and function in those with residual LV hypertrophy or elevated plasma renin activity.
AuthorsH Tomiyama, Y Kimura, Y Sakuma, K Matuno, H Yoshida, N Doba
JournalClinical and experimental hypertension (New York, N.Y. : 1993) (Clin Exp Hypertens) Vol. 22 Issue 5 Pg. 493-506 (Jul 2000) ISSN: 1064-1963 [Print] England
PMID10937840 (Publication Type: Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Calcium Channel Blockers
  • Cilazapril
  • Renin
Topics
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors (administration & dosage)
  • Calcium Channel Blockers (administration & dosage)
  • Carotid Arteries (drug effects, pathology, physiopathology)
  • Case-Control Studies
  • Cilazapril (administration & dosage)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypertension (drug therapy, pathology, physiopathology)
  • Hypertrophy, Left Ventricular (drug therapy, pathology, physiopathology)
  • Male
  • Middle Aged
  • Renin (blood)
  • Renin-Angiotensin System (genetics, physiology)
  • Ventricular Function, Left (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: